- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05421910
Clinical Feasibility of ROBERT-SAS in Severely Impaired Stroke Patients
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Rationale: Stroke is one of the leading causes of disability of adults in the European Union. Around 80% of stroke survivors experience deficits in motor control, resulting in problems with keeping balance and walking, for instance. The extent and amount of deficits differ per individual. Interventions to train the lower extremity almost always consist of walking exercises. However, patients in the acute phase or with severely affected lower extremity function are often unable to walk or to walk independently. Therefore, the combination of a robot (ROBERT®) and functional electrical stimulation (ES) is being developed to provide a training tool for early rehabilitation. In the current study a combination of robot and ES will be evaluated in clinical setting.
Objective: The primary objective of the current study is to assess the feasibility of ROBERT®-SAS training in clinical setting, in acute stroke patients, including patient and therapist perspectives.
Study design: The current study is an observational study.
Study population: In the current study ten (sub) acute stroke patient will be included, with severely affected lower extremity. Five of these ten will be included as soon as possible after arrival at the rehabilitation centre. Another five will be included 3-5 weeks after arrival/start of the rehabilitation.
Main study parameters/endpoints: The main outcome parameter is the SUS score from both the patients and the therapists.
Nature and extent of the burden and risks associated with participation, benefit and group relatedness: The current study consists of several measurement sessions in Roessingh Rehabilitation Centre, during the normal rehabilitation time. The robot, ROBERT® is CE-certified. However, the combination ROBERT®-SAS, combining both ES and robot support, is not, although previous tests have shown this approach is possible and tolerable by healthy persons and stroke patients. The risks are regarded as minimal because it is without invasive procedures, with room for rest in between trial sets as required by the participant, and application of individual stimulation profiles to not exceed tolerance levels or inflict pain during electrostimulation.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Overijssel
-
Enschede, Overijssel, Netherlands, 7522AH
- Roessingh Research and Development
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Sub(acute) stroke (< 6 months post-stroke)
- Above 18 years
- Able to provide informed consent
- An ischemic or haemorrhagic stroke
- Hemiparetic lower extremity
Exclusion Criteria:
- Premorbid disability of lower extremity
- Severe cognitive impairment, unable to follow simple instructions and unable to understand Dutch.
- Skin lesions at the hemiparetic leg
- Progressive neurological diseases (i.e. Parkinson, dementia, etc.)
- Contraindication for mobilization like unhealed lower limb fracture
- Use of pacemaker
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Device Feasibility
- Allocation: Non-Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Early training group
The early group will receive robotic training combined with electrical stimulation as soon as possible after submission to the rehab center.
With a frequency of three times a week for 3-5 weeks, dependent on the capabilities of the patients.
|
Active training of movements in supine position.
Movements such as knee extension and ankle dorsal flexion.
|
|
Active Comparator: Late training group
The late training group will receive robotic training combined with electrical stimulation 3-5 weeks after submission to the rehab center.
With a frequency of three times a week for 3-5 weeks, dependent on the capabilities of the patients.
|
Active training of movements in supine position.
Movements such as knee extension and ankle dorsal flexion.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
System Usability Scale (SUS) score
Time Frame: 15 minutes
|
The System Usability Scale of patients and therapists.
10 questions with a 5-point response scale.
The total score can range from 0 - 100, in which a higher score indicates a better usability
|
15 minutes
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Electromyography (EMG)
Time Frame: 30 minutes
|
Surface EMG of the muscle that will be stimulated with electrical stimulation, expressed in volt.
|
30 minutes
|
|
Force
Time Frame: 30 minutes
|
Resulting force measured with the robot, expressed in kg
|
30 minutes
|
|
Frequency
Time Frame: 30 minutes
|
As a settings of the stimulation expressed in Hertz
|
30 minutes
|
|
Assist-As-Needed (AAN) stages
Time Frame: 30 minutes
|
The trajectory completion rate for the different stages of AAN.
(different types of assistance).
There are three different types, no assistance, electrical stimulation assistance and an combination of electrical stimulation and robot support.
|
30 minutes
|
|
Fugl-Meyer Assessment (FMA)
Time Frame: 10 minutes
|
Lower extremity module, to assess leg function.
Scores can range between 0 and 28, in which a higher score indicates a higher leg function.
|
10 minutes
|
|
Motricity Index (MI)
Time Frame: 10 minutes
|
Lower extremity part, to assess the leg function.
Scored for Ankle, knee and hip separately between 0 - 33 in which zero is know movement and 33 is normal movement.
Total score can range between 0 - 99. (summation of the three joints)
|
10 minutes
|
|
Functional Ambulation Categories (FAC)
Time Frame: 5 minutes
|
To assess the walking capabilities, score between 0 and 5, in which 5 indicates a better walking capability.
|
5 minutes
|
|
Type of movement
Time Frame: 30 minutes
|
Type of movement that will be trained during the measurements.
Can be knee extension or ankle dorsal flexion with electrical stimulation.
|
30 minutes
|
|
Questionnaire Experience
Time Frame: 15 minutes
|
Questions about their experience with ROBERT for all stakeholders.
Open questions which will not have a score, but will be interpreted on question level.
|
15 minutes
|
|
Pulse width of the electrical stimulation
Time Frame: 30 minutes
|
As a settings of the stimulation expressed in milliseconds
|
30 minutes
|
|
Amplitude of the electrical stimulation
Time Frame: 30 Minutes
|
As a settings of the stimulation expressed in milliampere
|
30 Minutes
|
|
Amount of repetitions
Time Frame: 30 minutes
|
The amount of repetitions during one set of a specific movement.
|
30 minutes
|
|
Resistance level
Time Frame: 30 minutes
|
The amount of resistance during the training, can be changed during a set if necessary.
The resistance can differ between 0-10, in which 10 is the heaviest.
|
30 minutes
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Gender
Time Frame: 1 minutes
|
gender will be noted as subject characteristic
|
1 minutes
|
|
Age
Time Frame: 1 minutes
|
Age will be noted as subject characteristic in years
|
1 minutes
|
|
Time since stroke
Time Frame: 1 minutes
|
time science stroke will be noted as subject characteristic in months
|
1 minutes
|
|
Weight
Time Frame: 1 minutes
|
Weight will be noted as subject characteristic and used for BMI calculation, noted in kg
|
1 minutes
|
|
Height
Time Frame: 1 minutes
|
Height will be noted as subject characteristic and used for BMI calculation, noted in meters
|
1 minutes
|
|
Affected side
Time Frame: 1 minutes
|
The affected side will be used as subject characteristic
|
1 minutes
|
Collaborators and Investigators
Investigators
- Principal Investigator: Gerdienke Prange, PhD, Roessingh Research and Development
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- NL80574.000.22
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.